Skip to main content
Erschienen in: Cancer Causes & Control 6/2016

28.04.2016 | Original paper

A prospective study of oral contraceptive use and colorectal adenomas

verfasst von: Brittany M. Charlton, Edward Giovannucci, Charles S. Fuchs, Andrew T. Chan, Jung Eun Lee, Yin Cao, Stacey A. Missmer, Bernard A. Rosner, Susan E. Hankinson, Walter Willett, Kana Wu, Karin B. Michels

Erschienen in: Cancer Causes & Control | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The influence of reproductive factors on colorectal cancer, including oral contraceptive (OC) use, has been examined, but less research is available on OC use and adenomas.

Methods

Participants of the Nurses’ Health Study who had a lower bowel endoscopy between 1986 (when endoscopies were first assessed) and 2008 were included in this study. Multivariable logistic regression models for clustered data were used to estimate odds ratios and 95 % confidence intervals [OR (95 % CIs)].

Results

Among 73,058 participants, 51 % (n = 37,382) reported ever using OCs. Ever OC use was associated with a slight increase in non-advanced adenomas [OR 1.11, 95 % CI (1.02, 1.21)] but not with any other endpoints. Duration of OC use was not associated with adenomas, but longer times since last OC use were associated with increased odds of adenomas [e.g., compared to never use, 15+ years since last use: OR 1.17 (1.07, 1.27)]. Shorter times since last OC use were inversely associated [e.g., ≤4 years since last use: OR 0.74 (0.65, 0.84)].

Conclusions

We observed a modest borderline increase in risk of colorectal adenomas with any prior OC use. Additionally, more recent OC use may decrease risk, while exposure in the distant past may modestly increase risk of adenomas.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat La Vecchia C, Franceschi S (1991) Reproductive factors and colorectal cancer. Cancer Causes Control 2(3):193–200CrossRefPubMed La Vecchia C, Franceschi S (1991) Reproductive factors and colorectal cancer. Cancer Causes Control 2(3):193–200CrossRefPubMed
3.
Zurück zum Zitat Bostick RM, Potter JD, Kushi LH, Sellers TA, Steinmetz KA, McKenzie DR, Gapstur SM, Folsom AR (1994) Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5(1):38–52CrossRefPubMed Bostick RM, Potter JD, Kushi LH, Sellers TA, Steinmetz KA, McKenzie DR, Gapstur SM, Folsom AR (1994) Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5(1):38–52CrossRefPubMed
4.
Zurück zum Zitat Campbell PT, Newcomb P, Gallinger S, Cotterchio M, McLaughlin JR (2007) Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer. Cancer Causes Control 18(7):723–733. doi:10.1007/s10552-007-9015-7 CrossRefPubMed Campbell PT, Newcomb P, Gallinger S, Cotterchio M, McLaughlin JR (2007) Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer. Cancer Causes Control 18(7):723–733. doi:10.​1007/​s10552-007-9015-7 CrossRefPubMed
5.
Zurück zum Zitat Fernandez E, La Vecchia C, D’Avanzo B, Franceschi S, Negri E, Parazzini F (1996) Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer 73(11):1431–1435CrossRefPubMedPubMedCentral Fernandez E, La Vecchia C, D’Avanzo B, Franceschi S, Negri E, Parazzini F (1996) Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer 73(11):1431–1435CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Fernandez E, La Vecchia C, Franceschi S, Braga C, Talamini R, Negri E, Parazzini F (1998) Oral contraceptive use and risk of colorectal cancer. Epidemiology 9(3):295–300CrossRefPubMed Fernandez E, La Vecchia C, Franceschi S, Braga C, Talamini R, Negri E, Parazzini F (1998) Oral contraceptive use and risk of colorectal cancer. Epidemiology 9(3):295–300CrossRefPubMed
7.
Zurück zum Zitat Furner SE, Davis FG, Nelson RL, Haenszel W (1989) A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 49(17):4936–4940PubMed Furner SE, Davis FG, Nelson RL, Haenszel W (1989) A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 49(17):4936–4940PubMed
10.
Zurück zum Zitat Kabat GC, Miller AB, Rohan TE (2008) Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women. Int J Cancer 122(3):643–646. doi:10.1002/ijc.23079 CrossRefPubMed Kabat GC, Miller AB, Rohan TE (2008) Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women. Int J Cancer 122(3):643–646. doi:10.​1002/​ijc.​23079 CrossRefPubMed
11.
Zurück zum Zitat Kampman E, Bijl AJ, Kok C, van’t Veer P (1994) Reproductive and hormonal factors in male and female colon cancer. Eur J Cancer Prev 3(4):329–336CrossRefPubMed Kampman E, Bijl AJ, Kok C, van’t Veer P (1994) Reproductive and hormonal factors in male and female colon cancer. Eur J Cancer Prev 3(4):329–336CrossRefPubMed
12.
Zurück zum Zitat Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S (1997) Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 8(2):146–158CrossRefPubMed Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S (1997) Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 8(2):146–158CrossRefPubMed
13.
Zurück zum Zitat Levi F, Pasche C, Lucchini F, La Vecchia C (2003) Oral contraceptives and colorectal cancer. Dig Liver Dis 35(2):85–87CrossRefPubMed Levi F, Pasche C, Lucchini F, La Vecchia C (2003) Oral contraceptives and colorectal cancer. Dig Liver Dis 35(2):85–87CrossRefPubMed
14.
Zurück zum Zitat Lin J, Zhang SM, Cook NR, Manson JE, Buring JE, Lee IM (2007) Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study. Am J Epidemiol 165(7):794–801. doi:10.1093/aje/kwk068 CrossRefPubMed Lin J, Zhang SM, Cook NR, Manson JE, Buring JE, Lee IM (2007) Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study. Am J Epidemiol 165(7):794–801. doi:10.​1093/​aje/​kwk068 CrossRefPubMed
15.
Zurück zum Zitat Martinez ME, Grodstein F, Giovannucci E, Colditz GA, Speizer FE, Hennekens C, Rosner B, Willett WC, Stampfer MJ (1997) A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 6(1):1–5PubMed Martinez ME, Grodstein F, Giovannucci E, Colditz GA, Speizer FE, Hennekens C, Rosner B, Willett WC, Stampfer MJ (1997) A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 6(1):1–5PubMed
16.
17.
Zurück zum Zitat Potter JD, McMichael AJ (1983) Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst 71(4):703–709PubMed Potter JD, McMichael AJ (1983) Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst 71(4):703–709PubMed
18.
Zurück zum Zitat Talamini R, Franceschi S, Dal Maso L, Negri E, Conti E, Filiberti R, Montella M, Nanni O, La Vecchia C (1998) The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Eur J Cancer 34(7):1070–1076CrossRefPubMed Talamini R, Franceschi S, Dal Maso L, Negri E, Conti E, Filiberti R, Montella M, Nanni O, La Vecchia C (1998) The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Eur J Cancer 34(7):1070–1076CrossRefPubMed
19.
Zurück zum Zitat Troisi R, Schairer C, Chow WH, Schatzkin A, Brinton LA, Fraumeni JF Jr (1997) Reproductive factors, oral contraceptive use, and risk of colorectal cancer. Epidemiology 8(1):75–79CrossRefPubMed Troisi R, Schairer C, Chow WH, Schatzkin A, Brinton LA, Fraumeni JF Jr (1997) Reproductive factors, oral contraceptive use, and risk of colorectal cancer. Epidemiology 8(1):75–79CrossRefPubMed
20.
Zurück zum Zitat van Wayenburg CA, van der Schouw YT, van Noord PA, Peeters PH (2000) Age at menopause, body mass index, and the risk of colorectal cancer mortality in the Dutch Diagnostisch Onderzoek Mammacarcinoom (DOM) cohort. Epidemiology 11(3):304–308CrossRefPubMed van Wayenburg CA, van der Schouw YT, van Noord PA, Peeters PH (2000) Age at menopause, body mass index, and the risk of colorectal cancer mortality in the Dutch Diagnostisch Onderzoek Mammacarcinoom (DOM) cohort. Epidemiology 11(3):304–308CrossRefPubMed
22.
Zurück zum Zitat Wu-Williams AH, Lee M, Whittemore AS, Gallagher RP, Jiao DA, Zheng S, Zhou L, Wang XH, Chen K, Jung D et al (1991) Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 51(9):2307–2311PubMed Wu-Williams AH, Lee M, Whittemore AS, Gallagher RP, Jiao DA, Zheng S, Zhou L, Wang XH, Chen K, Jung D et al (1991) Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 51(9):2307–2311PubMed
23.
Zurück zum Zitat Jacobson JS, Neugut AI, Garbowski GC, Ahsan H, Waye JD, Treat MR, Forde KA (1995) Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States). Cancer Causes Control 6(6):513–518CrossRefPubMed Jacobson JS, Neugut AI, Garbowski GC, Ahsan H, Waye JD, Treat MR, Forde KA (1995) Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States). Cancer Causes Control 6(6):513–518CrossRefPubMed
24.
Zurück zum Zitat Peipins LA, Newman B, Sandler RS (1997) Reproductive history, use of exogenous hormones, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 6(9):671–675PubMed Peipins LA, Newman B, Sandler RS (1997) Reproductive history, use of exogenous hormones, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 6(9):671–675PubMed
25.
Zurück zum Zitat Platz EA, Martinez ME, Grodstein F, Fuchs CS, Colditz GA, Stampfer MJ, Giovannucci E (1997) Parity and other reproductive factors and risk of adenomatous polyps of the distal colorectum (United States). Cancer Causes Control 8(6):894–903CrossRefPubMed Platz EA, Martinez ME, Grodstein F, Fuchs CS, Colditz GA, Stampfer MJ, Giovannucci E (1997) Parity and other reproductive factors and risk of adenomatous polyps of the distal colorectum (United States). Cancer Causes Control 8(6):894–903CrossRefPubMed
26.
Zurück zum Zitat Grodstein F, Martinez ME, Platz EA, Giovannucci E, Colditz GA, Kautzky M, Fuchs C, Stampfer MJ (1998) Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 128(9):705–712CrossRefPubMed Grodstein F, Martinez ME, Platz EA, Giovannucci E, Colditz GA, Kautzky M, Fuchs C, Stampfer MJ (1998) Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 128(9):705–712CrossRefPubMed
28.
Zurück zum Zitat Hebert-Croteau N (1998) A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 7(8):653–659PubMed Hebert-Croteau N (1998) A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 7(8):653–659PubMed
29.
Zurück zum Zitat Potter JD, Bostick RM, Grandits GA, Fosdick L, Elmer P, Wood J, Grambsch P, Louis TA (1996) Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev 5(10):779–784PubMed Potter JD, Bostick RM, Grandits GA, Fosdick L, Elmer P, Wood J, Grambsch P, Louis TA (1996) Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev 5(10):779–784PubMed
30.
Zurück zum Zitat Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333CrossRefPubMed Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333CrossRefPubMed
31.
Zurück zum Zitat Wolf LA, Terry PD, Potter JD, Bostick RM (2007) Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Cancer Epidemiol Biomarkers Prev 16(4):676–683. doi:10.1158/1055-9965.EPI-06-0883 CrossRefPubMed Wolf LA, Terry PD, Potter JD, Bostick RM (2007) Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Cancer Epidemiol Biomarkers Prev 16(4):676–683. doi:10.​1158/​1055-9965.​EPI-06-0883 CrossRefPubMed
32.
Zurück zum Zitat Woodson K, Lanza E, Tangrea JA, Albert PS, Slattery M, Pinsky J, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A (2001) Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. J Natl Cancer Inst 93(23):1799–1805CrossRefPubMed Woodson K, Lanza E, Tangrea JA, Albert PS, Slattery M, Pinsky J, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A (2001) Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. J Natl Cancer Inst 93(23):1799–1805CrossRefPubMed
33.
Zurück zum Zitat McMichael AJ, Potter JD (1980) Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 65(6):1201–1207PubMed McMichael AJ, Potter JD (1980) Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 65(6):1201–1207PubMed
35.
Zurück zum Zitat Campagnoli C, Biglia N, Altare F, Lanza MG, Lesca L, Cantamessa C, Peris C, Fiorucci GC, Sismondi P (1993) Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol 7(4):251–258CrossRefPubMed Campagnoli C, Biglia N, Altare F, Lanza MG, Lesca L, Cantamessa C, Peris C, Fiorucci GC, Sismondi P (1993) Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol 7(4):251–258CrossRefPubMed
37.
Zurück zum Zitat Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, Jacobson JS, Fenoglio-Preiser CM, Potter JD (2002) Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 11(7):622–629PubMed Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, Jacobson JS, Fenoglio-Preiser CM, Potter JD (2002) Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 11(7):622–629PubMed
38.
Zurück zum Zitat Belanger CF, Hennekens CH, Rosner B, Speizer FE (1978) The nurses’ health study. Am J Nurs 78(6):1039–1040PubMed Belanger CF, Hennekens CH, Rosner B, Speizer FE (1978) The nurses’ health study. Am J Nurs 78(6):1039–1040PubMed
39.
Zurück zum Zitat Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1(6):466–473CrossRefPubMed Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1(6):466–473CrossRefPubMed
40.
Zurück zum Zitat Therneau TM, Hamilton SA (1997) rhDNase as an example of recurrent event analysis. Stat Med 16(18):2029–2047CrossRefPubMed Therneau TM, Hamilton SA (1997) rhDNase as an example of recurrent event analysis. Stat Med 16(18):2029–2047CrossRefPubMed
41.
Zurück zum Zitat Colin EM, Van Den Bemd GJ, Van Aken M, Christakos S, De Jonge HR, Deluca HF, Prahl JM, Birkenhager JC, Buurman CJ, Pols HA, Van Leeuwen JP (1999) Evidence for involvement of 17beta-estradiol in intestinal calcium absorption independent of 1,25-dihydroxyvitamin D3 level in the Rat. J Bone Miner Res 14(1):57–64. doi:10.1359/jbmr.1999.14.1.57 CrossRefPubMed Colin EM, Van Den Bemd GJ, Van Aken M, Christakos S, De Jonge HR, Deluca HF, Prahl JM, Birkenhager JC, Buurman CJ, Pols HA, Van Leeuwen JP (1999) Evidence for involvement of 17beta-estradiol in intestinal calcium absorption independent of 1,25-dihydroxyvitamin D3 level in the Rat. J Bone Miner Res 14(1):57–64. doi:10.​1359/​jbmr.​1999.​14.​1.​57 CrossRefPubMed
42.
Zurück zum Zitat Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7(4):536–540. doi:10.1038/ng0894-536 CrossRefPubMed Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7(4):536–540. doi:10.​1038/​ng0894-536 CrossRefPubMed
43.
Zurück zum Zitat Lointier P, Wildrick DM, Boman BM (1992) The effects of steroid hormones on a human colon cancer cell line in vitro. Anticancer Res 12(4):1327–1330PubMed Lointier P, Wildrick DM, Boman BM (1992) The effects of steroid hormones on a human colon cancer cell line in vitro. Anticancer Res 12(4):1327–1330PubMed
45.
Zurück zum Zitat Oshima CT, Wonraht DR, Catarino RM, Mattos D, Forones NM (1999) Estrogen and progesterone receptors in gastric and colorectal cancer. Hepatogastroenterology 46(30):3155–3158PubMed Oshima CT, Wonraht DR, Catarino RM, Mattos D, Forones NM (1999) Estrogen and progesterone receptors in gastric and colorectal cancer. Hepatogastroenterology 46(30):3155–3158PubMed
46.
Zurück zum Zitat Schwartz B, Smirnoff P, Shany S, Liel Y (2000) Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon. Mol Cell Biochem 203(1–2):87–93CrossRefPubMed Schwartz B, Smirnoff P, Shany S, Liel Y (2000) Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon. Mol Cell Biochem 203(1–2):87–93CrossRefPubMed
47.
Zurück zum Zitat Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD (2003) Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 14(1):75–84CrossRefPubMed Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD (2003) Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 14(1):75–84CrossRefPubMed
48.
Zurück zum Zitat Smirnoff P, Liel Y, Gnainsky J, Shany S, Schwartz B (1999) The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol Res 11(6):255–264PubMed Smirnoff P, Liel Y, Gnainsky J, Shany S, Schwartz B (1999) The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol Res 11(6):255–264PubMed
50.
Zurück zum Zitat Piper JM, Kennedy DL (1987) Oral contraceptives in the United States: trends in content and potency. Int J Epidemiol 16(2):215–221CrossRefPubMed Piper JM, Kennedy DL (1987) Oral contraceptives in the United States: trends in content and potency. Int J Epidemiol 16(2):215–221CrossRefPubMed
Metadaten
Titel
A prospective study of oral contraceptive use and colorectal adenomas
verfasst von
Brittany M. Charlton
Edward Giovannucci
Charles S. Fuchs
Andrew T. Chan
Jung Eun Lee
Yin Cao
Stacey A. Missmer
Bernard A. Rosner
Susan E. Hankinson
Walter Willett
Kana Wu
Karin B. Michels
Publikationsdatum
28.04.2016
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 6/2016
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0752-3

Weitere Artikel der Ausgabe 6/2016

Cancer Causes & Control 6/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.